Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Merck
Chubb
Baxter
Federal Trade Commission
UBS
Novartis
Covington
Cerilliant

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020882

« Back to Dashboard

NDA 020882 describes NEURONTIN, which is a drug marketed by Pfizer Pharms and Parke Davis and is included in three NDAs. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the NEURONTIN profile page.

The generic ingredient in NEURONTIN is gabapentin. There are twenty-eight drug master file entries for this compound. One hundred and seven suppliers are listed for this compound. Additional details are available on the gabapentin profile page.
Summary for 020882
Tradename:NEURONTIN
Applicant:Pfizer Pharms
Ingredient:gabapentin
Patents:0
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details
Pharmacology for NDA: 020882
Suppliers and Packaging for NDA: 020882
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEURONTIN gabapentin TABLET;ORAL 020882 NDA Parke-Davis Div of Pfizer Inc 0071-0401 N 0071-0401-24
NEURONTIN gabapentin TABLET;ORAL 020882 NDA Parke-Davis Div of Pfizer Inc 0071-0513 N 0071-0513-24

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength600MG
Approval Date:Oct 9, 1998TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength800MG
Approval Date:Oct 9, 1998TE:ABRLD:Yes

Expired US Patents for NDA 020882

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Pharms NEURONTIN gabapentin TABLET;ORAL 020882-001 Oct 9, 1998 ➤ Sign Up ➤ Sign Up
Pfizer Pharms NEURONTIN gabapentin TABLET;ORAL 020882-001 Oct 9, 1998 ➤ Sign Up ➤ Sign Up
Pfizer Pharms NEURONTIN gabapentin TABLET;ORAL 020882-002 Oct 9, 1998 ➤ Sign Up ➤ Sign Up
Pfizer Pharms NEURONTIN gabapentin TABLET;ORAL 020882-002 Oct 9, 1998 ➤ Sign Up ➤ Sign Up
Pfizer Pharms NEURONTIN gabapentin TABLET;ORAL 020882-002 Oct 9, 1998 ➤ Sign Up ➤ Sign Up
Pfizer Pharms NEURONTIN gabapentin TABLET;ORAL 020882-002 Oct 9, 1998 ➤ Sign Up ➤ Sign Up
Pfizer Pharms NEURONTIN gabapentin TABLET;ORAL 020882-001 Oct 9, 1998 ➤ Sign Up ➤ Sign Up
Pfizer Pharms NEURONTIN gabapentin TABLET;ORAL 020882-001 Oct 9, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Cerilliant
US Department of Justice
McKinsey
Argus Health
Deloitte
Medtronic
Julphar
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot